{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:07:02Z","timestamp":1792037222503,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The kidney\u2019s endocrine function is essential for maintaining body homeostasis. Erythropoietin (EPO) is one of the key endocrine factors produced by the kidney, and kidney disease patients frequently experience anemia due to impaired EPO production. In the present study we explored the potential of human induced pluripotent stem cell (iPSC)-derived kidney organoids to restore EPO production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EPO secretion by kidney organoids was examined under 1% and 20% oxygen levels. To increase the EPO secreting capacity of kidney organoids, iPSC were genetically engineered with a non-integrating scaffold\/matrix attachment region (S\/MAR) DNA vector containing the EPO gene and generated EPO-overexpressing (EPO+) kidney organoids. To assess the physiological effects of EPO\u2009+\u2009organoids, 2\u20138 organoids were implanted subcutaneously in immunodeficient mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Kidney organoids produced low amounts of EPO under 1% oxygen. EPO S\/MAR DNA vectors persisted and continued to robustly express EPO during iPSC expansion and kidney organoid differentiation without interfering with cellular proliferation. EPO\u2009+\u2009iPSC demonstrated efficient differentiation into kidney organoids. One-month post-implantation, EPO\u2009+\u2009organoids displayed continuously elevated EPO mRNA levels and significantly increased endothelial cell numbers compared to control organoids. Hematocrit levels were notably elevated in mice implanted with EPO\u2009+\u2009organoids in an organoid number-dependent manner. EPO\u2009+\u2009organoids furthermore influenced bone homeostasis in their hosts, evidenced by a change in trabecular bone composition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Kidney organoids modified by EPO S\/MAR DNA vector allow stable long-term delivery of EPO. The observed physiological effects following the implantation of EPO\u2009+\u2009organoids underscore the potential of gene-edited kidney organoids for endocrine restoration therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04282-w","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:43:51Z","timestamp":1744476231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector"],"prefix":"10.1186","volume":"16","author":[{"given":"Z.","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bas-Crist\u00f3bal Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ratsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.P.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Clahsen-van Groningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gribnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.J.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Baan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van der Eerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Harbottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0217-8254","authenticated-orcid":false,"given":"Martin J.","family":"Hoogduijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"10","key":"4282_CR1","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL 1 Babitt","year":"2012","unstructured":"1 Babitt JL, Lin HY. Mechanisms of anemia in CKD [in eng]. J Am Soc Nephrol. 2012;23(10):1631\u20134.","journal-title":"J Am Soc Nephrol"},{"key":"4282_CR2","doi-asserted-by":"publisher","first-page":"642296","DOI":"10.3389\/fmed.2021.642296","volume":"8","author":"J Portoles","year":"2021","unstructured":"Portoles J, Martin L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents [in eng]. Front Med (Lausanne). 2021;8:642296.","journal-title":"Front Med (Lausanne)"},{"issue":"10075","key":"4282_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease [in eng]. Lancet. 2017;389(10075):1238\u201352.","journal-title":"Lancet"},{"issue":"6","key":"4282_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/sctm.20-0387","volume":"10","author":"KM Lappin","year":"2021","unstructured":"Lappin KM, Mills KI, Lappin TR. Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy [in eng]. Stem Cells Transl Med. 2021;10(6):836\u201343.","journal-title":"Stem Cells Transl Med"},{"key":"4282_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphys.2015.00167","volume":"6","author":"T Souma","year":"2015","unstructured":"Souma T, Suzuki N, Yamamoto M. Renal erythropoietin-producing cells in health and disease [in eng]. Front Physiol. 2015;6:167.","journal-title":"Front Physiol"},{"issue":"9","key":"4282_CR6","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.1096\/fj.202000888R","volume":"34","author":"S Suresh","year":"2020","unstructured":"Suresh S, Lee J, Noguchi CT. Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis [in eng]. FASEB J. 2020;34(9):11685\u201397.","journal-title":"FASEB J"},{"issue":"2","key":"4282_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM198701083160203","volume":"316","author":"JW Eschbach","year":"1987","unstructured":"Eschbach JW, Egrie JC, Downing MR, et al. Correction of the anemia of end-stage renal disease with Recombinant human erythropoietin. Results of a combined phase I and II clinical trial [in eng]. N Engl J Med. 1987;316(2):73\u20138.","journal-title":"N Engl J Med"},{"issue":"8517","key":"4282_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","volume":"2","author":"CG Winearls","year":"1986","unstructured":"Winearls CG, Oliver DO, Pippard MJ, et al. Effect of human erythropoietin derived from Recombinant DNA on the anaemia of patients maintained by chronic haemodialysis [in eng]. Lancet. 1986;2(8517):1175\u20138.","journal-title":"Lancet"},{"issue":"3","key":"4282_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/MNH.0000000000000317","volume":"26","author":"D Collister","year":"2017","unstructured":"Collister D, Rigatto C, Tangri N. Anemia management in chronic kidney disease and dialysis: a narrative review [in eng]. Curr Opin Nephrol Hypertens. 2017;26(3):214\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"4282_CR10","doi-asserted-by":"publisher","first-page":"e056390","DOI":"10.1136\/bmjopen-2021-056390","volume":"12","author":"CY Cheng","year":"2022","unstructured":"Cheng CY, Kuo YJ. Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance Dialysis patients [in eng]. BMJ Open. 2022;12(4):e056390.","journal-title":"BMJ Open"},{"issue":"6","key":"4282_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ndt\/gfz031","volume":"35","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, Del Vecchio L. Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease? [in eng]. Nephrol Dial Transpl. 2020;35(6):926\u201332.","journal-title":"Nephrol Dial Transpl"},{"key":"4282_CR12","doi-asserted-by":"crossref","unstructured":"Hitomi H, Kasahara T, Katagiri N et al. Human pluripotent stem cell-derived erythropoietin-producing cells ameliorate renal anemia in mice [in eng]. Sci Transl Med 2017;9(409).","DOI":"10.1126\/scitranslmed.aaj2300"},{"issue":"3","key":"4282_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/2211-5463.12800","volume":"10","author":"S Nishimoto","year":"2020","unstructured":"Nishimoto S, Mizuno T, Takahashi K, et al. CD140b and CD73 are markers for human induced pluripotent stem cell-derived erythropoietin-producing cells [in eng]. FEBS Open Bio. 2020;10(3):427\u201333.","journal-title":"FEBS Open Bio"},{"issue":"1","key":"4282_CR14","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1038\/s41598-021-83431-6","volume":"11","author":"N Katagiri","year":"2021","unstructured":"Katagiri N, Hitomi H, Mae SI, et al. Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells [in eng]. Sci Rep. 2021;11(1):3936.","journal-title":"Sci Rep"},{"key":"4282_CR15","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.scr.2021.102476","volume":"55","author":"V Brizi","year":"2021","unstructured":"Brizi V, Butto S, Cerullo D, et al. Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic mice [in eng]. Stem Cell Res. 2021;55:102476.","journal-title":"Stem Cell Res"},{"issue":"2","key":"4282_CR16","doi-asserted-by":"publisher","first-page":"113602","DOI":"10.1016\/j.celrep.2023.113602","volume":"43","author":"H Tsujimoto","year":"2024","unstructured":"Tsujimoto H, Hoshina A, Mae SI, et al. Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells [in eng]. Cell Rep. 2024;43(2):113602.","journal-title":"Cell Rep"},{"issue":"7574","key":"4282_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato M, Er PX, Chiu HS, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis [in eng]. Nature. 2015;526(7574):564\u20138.","journal-title":"Nature"},{"issue":"1","key":"4282_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.kint.2020.08.008","volume":"99","author":"AS Shankar","year":"2021","unstructured":"Shankar AS, Du Z, Mora HT, et al. Human kidney organoids produce functional Renin [in eng]. Kidney Int. 2021;99(1):134\u201347.","journal-title":"Kidney Int"},{"issue":"1","key":"4282_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/ndt\/gfab264","volume":"37","author":"AS Shankar","year":"2021","unstructured":"Shankar AS, van den Berg SAA, Tejeda Mora H, et al. Vitamin D metabolism in human kidney organoids [in eng]. Nephrol Dial Transpl. 2021;37(1):190\u20133.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"4282_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.stemcr.2018.01.041","volume":"10","author":"CW van den Berg","year":"2018","unstructured":"van den Berg CW, Ritsma L, Avramut MC, et al. Renal subcapsular transplantation of PSC-Derived kidney organoids induces Neo-vasculogenesis and significant glomerular and tubular maturation in vivo [in eng]. Stem Cell Rep. 2018;10(3):751\u201365.","journal-title":"Stem Cell Rep"},{"key":"4282_CR21","doi-asserted-by":"crossref","unstructured":"Koning M, Lievers E, Jaffredo T et al. Efficient vascularization of kidney organoids through intracelomic transplantation in chicken embryos [in eng]. J Vis Exp 2023(192).","DOI":"10.3791\/65090"},{"key":"4282_CR22","doi-asserted-by":"crossref","unstructured":"Bozza M, De Roia A, Correia MP et al. A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of Recombinant T cells [in eng]. Sci Adv 2021;7(16).","DOI":"10.1126\/sciadv.abf1333"},{"issue":"1","key":"4282_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2021.11.011","volume":"17","author":"A Roig-Merino","year":"2022","unstructured":"Roig-Merino A, Urban M, Bozza M, et al. An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny [in eng]. Stem Cell Rep. 2022;17(1):143\u201358.","journal-title":"Stem Cell Rep"},{"key":"4282_CR24","doi-asserted-by":"crossref","unstructured":"Kreppel F, Hagedorn C. Episomes and Transposases-Utilities to maintain transgene expression from nonviral vectors [in eng]. Genes (Basel) 2022;13(10).","DOI":"10.3390\/genes13101872"},{"issue":"4","key":"4282_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.stemcr.2014.07.013","volume":"3","author":"CE de Esch","year":"2014","unstructured":"de Esch CE, Ghazvini M, Loos F, et al. Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation [in eng]. Stem Cell Rep. 2014;3(4):548\u201355.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"4282_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41563-019-0287-6","volume":"18","author":"E Garreta","year":"2019","unstructured":"Garreta E, Prado P, Tarantino C, et al. Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells [in eng]. Nat Mater. 2019;18(4):397\u2013405.","journal-title":"Nat Mater"},{"key":"4282_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-1-0716-1174-6_12","volume":"2258","author":"IL Selfa","year":"2021","unstructured":"Selfa IL, Gallo M, Montserrat N, Garreta E. Directed differentiation of human pluripotent stem cells for the generation of High-Order kidney organoids [in eng]. Methods Mol Biol. 2021;2258:171\u201392.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"4282_CR28","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, et al. QuPath: open source software for digital pathology image analysis [in eng]. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"1","key":"4282_CR29","first-page":"e100115","volume":"4","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research [in eng]. BMJ Open Sci. 2020;4(1):e100115.","journal-title":"BMJ Open Sci"},{"issue":"7","key":"4282_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography [in eng]. J Bone Min Res. 2010;25(7):1468\u201386.","journal-title":"J Bone Min Res"},{"issue":"8","key":"4282_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00424-016-1829-2","volume":"468","author":"K Gerl","year":"2016","unstructured":"Gerl K, Nolan KA, Karger C, et al. Erythropoietin production by PDGFR-beta(+) cells [in eng]. Pflugers Arch. 2016;468(8):1479\u201387.","journal-title":"Pflugers Arch"},{"key":"4282_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.omtm.2020.04.017","volume":"17","author":"M Bozza","year":"2020","unstructured":"Bozza M, Green EW, Espinet E, et al. Novel Non-integrating DNA Nano-S\/MAR vectors restore gene function in isogenic Patient-Derived pancreatic tumor models [in eng]. Mol Ther Methods Clin Dev. 2020;17:957\u201368.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"4282_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","volume":"52","author":"SE Juul","year":"1998","unstructured":"Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus [in eng]. Early Hum Dev. 1998;52(3):235\u201349.","journal-title":"Early Hum Dev"},{"issue":"10","key":"4282_CR34","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1182\/blood-2002-01-0301","volume":"99","author":"V Divoky","year":"2002","unstructured":"Divoky V, Prchal JT. Mouse surviving solely on human erythropoietin receptor (EpoR): model of human EpoR-linked disease [in eng]. Blood. 2002;99(10):3873\u20134. author reply 3874\u20133875.","journal-title":"Blood"},{"key":"4282_CR35","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1146\/annurev.ph.51.030189.004213","volume":"51","author":"C Bauer","year":"1989","unstructured":"Bauer C, Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production [in eng]. Annu Rev Physiol. 1989;51:845\u201356.","journal-title":"Annu Rev Physiol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04282-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04282-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04282-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:43:53Z","timestamp":1744476233000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04282-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4282"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04282-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5534834\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"iPSC were generated from human donors as part of the project \u2018Creation of disease model systems to understand and correct genetic diseases through gene or other therapy using iPS cell derived from somatic cells: IPSC protocol Rotterdam\u2019 approved by the Erasmus MC Medical Ethical Committee under approval number MEC-2017-248, which was published 29th March 2018 and last updated 15th April 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal studies were part of the project \u2018Regenerative and immunomodulatory therapies to improve the outcome of kidney transplantation\u2019, which received approval of the Dutch central committee animal experiments on 22nd Sept 2022 under license number AVD101002016635.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement on animal experiments"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of artificial intelligence (AI)"}}],"article-number":"174"}}